QR Code

Quantitative G6PD Deficiency Screening in Routine Malaria Diagnostic Units in the Brazilian Amazon (SAFEPRIM): An Operational Mixed-Methods Study

Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency testing is not routinely performed before primaquine treatment in most <i>Plasmodium vivax</i> endemic areas, despite the risk of primaquine-associated hemolysis. This is due to the operational challenges associated with pragmatic G6PD...

Full description

Saved in:
Main Authors: Jose Diego Brito-Sousa, Felipe Murta, Sheila Vitor-Silva, Vanderson Sampaio, Maxwell Mendes, Brenda Souza, Talita Batista, Alicia Santos, Leonardo Marques, Laila Barbosa, Patricia Balieiro, Alexandre Silva-Neto, Renata Rabello, Marcelo Brito, Emanuelle Silva, Sheila Rodovalho, Ana Ruth Arcanjo, Gisely Melo, Judith Recht, Gonzalo J. Domingo, Suiane Valle, Rodrigo Souza, Theresa Nakagawa, Wuelton Monteiro, Marcus Lacerda
Format: Artigo
Language:Inglês
Published: MDPI AG 2022-11-01
Series:Pathogens
Subjects:
G6PD deficiency
<i>Plasmodium vivax</i>
implementation
malaria
elimination
primaquine
Online Access:https://www.mdpi.com/2076-0817/11/11/1328
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items